Results
2739
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,739 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$143.66 | 0.2% | -11.1% | US$347.2b | US$172.43 | PE23.4x | E9.4% | 3.5% | Pharmaceuticals & Biotech | ||
AZN | UK£107.12 | 2.9% | -0.6% | UK£166.1b | UK£142.38 | PE32x | E16.8% | 2.2% | Pharmaceuticals & Biotech | ||
HSBA | UK£7.85 | 0.4% | 22.6% | UK£138.3b | UK£8.54 | PB0.9x | E-1.2% | 6.2% | Banks | ||
CBA | AU$157.11 | 2.5% | 39.0% | AU$260.9b | AU$99.32 | PB3.6x | E4.4% | 3.0% | Banks | ||
PFE | US$26.89 | 1.8% | -9.1% | US$150.7b | US$31.86 | PE35.7x | E9.5% | 6.4% | Pharmaceuticals & Biotech | ||
LOW | US$249.74 | 1.2% | 15.0% | US$140.3b | US$283.15 | PE20.6x | E5.9% | 1.8% | Retail | ||
COP | US$99.99 | 3.0% | -12.7% | US$130.8b | US$132.47 | PE13x | E2.2% | 3.7% | Energy | ||
BHP | AU$38.70 | -2.1% | -21.0% | AU$197.7b | AU$46.68 | PE15.5x | E6.1% | 6.0% | Materials | ||
TD | CA$77.78 | 2.0% | -10.5% | CA$136.1b | CA$84.36 | PB1.2x | E14.5% | 5.4% | Banks | ||
INVE A | SEK 296.90 | 1.6% | 29.8% | SEK 909.0b | SEK 303.50 | PE4.4x | E-55.0% | 1.6% | Diversified Financials | ||
BREN | Rp9,800.00 | 5.7% | 45.2% | Rp1311.1t | n/a | PE742.7x | n/a | 0.04% | Utilities | ||
BP. | UK£4.14 | 7.1% | -10.3% | UK£64.8b | UK£4.95 | PE29.8x | E24.1% | 6.0% | Energy | ||
1299 | HK$55.25 | -1.9% | -12.3% | HK$594.5b | HK$92.99 | PE15.8x | E13.9% | 2.9% | Insurance | ||
ITW | US$250.36 | -1.8% | -2.7% | US$74.5b | US$263.84 | PE21.4x | E1.1% | 2.4% | Capital Goods | ||
ATCO A | SEK 171.65 | 1.7% | 5.2% | SEK 807.5b | SEK 189.04 | PE29.1x | E7.4% | 1.6% | Capital Goods | ||
NAB | AU$37.82 | 1.9% | 22.4% | AU$116.1b | AU$33.53 | PB1.9x | E2.3% | 4.5% | Banks | ||
WBC | AU$32.87 | 1.7% | 42.3% | AU$112.3b | AU$28.32 | PB1.6x | E-0.03% | 4.6% | Banks | ||
DGE | UK£25.04 | -0.4% | -9.6% | UK£55.6b | UK£27.05 | PE18x | E3.8% | 3.3% | Food, Beverage & Tobacco | ||
GSK | UK£13.50 | 1.2% | -12.9% | UK£55.1b | UK£18.16 | PE21.9x | E20.0% | 4.3% | Pharmaceuticals & Biotech | ||
SPG | US$174.41 | 2.1% | 22.6% | US$66.1b | US$186.03 | PB21.3x | E0.6% | 4.8% | Real Estate | ||
FDX | US$273.97 | -2.3% | 10.2% | US$66.1b | US$325.88 | PE17x | E13.4% | 2.0% | Transportation | ||
CNR | CA$148.53 | 2.6% | -11.2% | CA$93.2b | CA$172.95 | PE17.2x | E4.4% | 2.3% | Transportation | ||
CRH | US$93.61 | 1.2% | 35.9% | US$63.2b | US$113.41 | PE18.4x | E8.8% | 1.5% | Materials | ||
CPG | UK£26.43 | -0.4% | 22.5% | UK£44.9b | UK£27.05 | PE40x | E17.0% | 1.8% | Consumer Services |